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Am J Geriatr PsObjective: To test the following hypotheses: (1) Clinical case management integrated
with problem-solving therapy (CM-PST) is more effective than clinical case manage-
ment alone (CM) in improving functional outcomes in disabled, impoverished
patients and (2) improvement in depression, self-efﬁcacy, and problem-solving skills
mediates improvement of disability. Methods: Using a randomized controlled trial
with a parallel design, 271 individuals were screened and 171 were randomized to
12 weekly sessions of either CM or CM-PST at 1:1 ratio. Raters were blind to patients’
assignments. Participants were at least age 60 years with major depression, had at
least one disability, were eligible for home-based meals services, and had income no
more than 30% of their counties’ median. The WHO Disability Assessment Scale was
used. Results: Both interventions resulted in improved functioning by 12 weeks (t ¼
4.28, df ¼ 554, p ¼ 0.001), which was maintained until 24 weeks. Contrary to hy-
pothesis, CM was noninferior to CM-PST (one-sided p ¼ 0.0003, t ¼ 3.5, df ¼ 558).
Change in disability was not affected by baseline depression severity, cognitive
function, or number of unmet social service needs. Improvements in self efﬁcacy
(t ¼ 2.45, df ¼ 672, p ¼ 0.021), problem-solving skill (t ¼ 2.44, df ¼ 546, p ¼
0.015), and depression symptoms (t ¼ 2.25, df ¼ 672, p ¼ .025) by week 9 predicted
improvement in function across groups by week 12. Conclusion: CM is noninferior
to CM-PST for late-life depression in low-income populations. The effect of these
interventions occur early, with beneﬁts in functional status maintained as long as 24
weeks after treatment initiation (clinicaltrials.gov; NCT00540865). (Am J Geriatr
Psychiatry 2015; 23:1307e1314)
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CM-PST vs. CM for Late-Life DisabilityINTRODUCTION
Disability in older adults is a major public health
concern with numerous causes, the most common
being depression.1,2 In 2012, the World Health Orga-
nization (WHO) listed depression as the leading
source of disability globally and a major contributor to
disease burden worldwide.3 Studies in older adults
show that the likelihood of becoming disabled in-
creases with each new symptom of depression and
that the likelihood of recovering from a disability
decreases as depression symptoms increase.4,5 This is
particularly true for older adults living in poverty. The
number of older adults living in poverty is high, with
8.1% of U.S. adults aged 65e74 and 10% of those over
75 living below the ofﬁcial poverty line.6 Older adults
living in poverty are 2.6 times more likely to suffer
from depression than middle-income older adults and
are more likely to be disabled as a consequence.7e10
The comorbidity of depression and disability in low-
income older adults is high11,12 and increases the
cost of healthcare in the United States. These costs are
largely due to the disabling effects of depression13 and
could be reduced if depression and the accompanying
disability were treated effectively.14e17
A number of studies demonstrated the effect of
depression treatment on disability in healthy older
adults,18,19 yet few large-scale clinical trials have
investigated the impact of depression treatments on
disability in low-income adults with physical limita-
tions. A complexity of treating depression in low-
income older adults is the limited access and
acceptability of depression treatment. Low-income
older adults prefer counseling-based interventions
to medication management20,21 and when treated
with medications show poor compliance22e24 and
poor outcomes.25 Psychotherapy, although preferred
by this population, is limited in its availability and in
its ability to address the social needs of people living
in poverty.26,27 Disabled, impoverished older adults
experience numerous social and environmental
stressors that require case management (CM)
interventions to address unmet needs in a way that
antidepressants and psychotherapy cannot.27e30
Although psychotherapy may address disability
through resolution of the depressive syndrome, CM
has the potential to augment this effect by linking
disabled, impoverished elders to social, medical, and1308rehabilitative services that may directly address
behavioral and physical limitations.30e32
Given the preference for psychotherapies and the
need for CM services, we developed an intervention
that combines problem-solving therapy (PST)33 with
clinical CM.27 Our decision to combine these two
interventions was based on their potential synergy.
We conceptualized CM as an intervention that pro-
vides access to social and medical resources and en-
titlements. Accordingly, it creates an environment in
which a person with disability can maximize his or
her function and reduce the experience of stress. CM
has a beneﬁcial effect on disability in adults.34 PST
can provide patients with the skills to use the re-
sources made available by CM by setting goals and
developing strategies to meet these goals on their
own. Thus, we reasoned that combining CM with
PST (CM-PST) has the best chance to reduce disability
by providing access to much needed ﬁnancial, social,
and medical resources and by helping impoverished,
depressed, disabled older adults develop the skills to
use them. Based on the same reasoning, we further
hypothesized that the advantage of CM-PST over CM
alone in reducing disability would be mediated by
reduction in depression and improvement in
problem-solving skills and self-efﬁcacy.
We already reported in this journal that CM was
noninferior to CM-PST in reducing depression in a
sample of disabled, impoverished, older adults with
major depression.35 This is the ﬁrst report on the pri-
mary hypothesis of this study comparing the efﬁcacy of
CM-PST to that of CM alone in reducing disability.
Further analyses examined whether change in depres-
sion severity, problem-solving skills, and sense of self-
efﬁcacy during this trial inﬂuenced disability at the
end of the trial. Finally, we examined the moderating
effects of unmet social service needs, depression
severity, and cognitive functioning before treatment on
differences in efﬁcacy between interventions to deter-
mine for whom these treatmentsmay bemost effective.METHODS
Participants
Participants were recruited from neighboring
home-based meals programs near the two research
sites, the Weill Cornell Institute of GeriatricAm J Geriatr Psychiatry 23:12, December 2015
Areán et al.Psychiatry and the University of California, San
Francisco. Participants had been receiving unstruc-
tured CM as part of their membership in the home-
based meals program and were referred to the
study by their social workers. Study procedures were
approved by the institutional review boards of both
universities, and all participants completed an
informed consent. Participants were informed that
this was a study comparing the effects of two treat-
ments on depression and disability in older adults.
All baseline and follow-up assessments were con-
ducted in person, as were all therapy sessions.
Eligibility criteria were as follows: age at least 60
years, participation in a home-delivered meals ser-
vice, at least one impaired instrumental activity of
daily living (assessed using the multilevel assessment
instrument),36 low-income deﬁned by the U.S.
Department of Housing and Urban Development as
extreme ﬁnancial strain (30% of the local median
income), at least one unmet social service need on the
Camberwell Assessment of Need for the Elderly
(CANE; e.g., access to healthcare, transportation, so-
cial services, entitlements, meals, need for in-home
support),37,38 diagnosis for unipolar major depres-
sion (deﬁned by Structured Clinical Interview for
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition [SCID and DSM-IV]),39 24-item Ham-
ilton Depression Rating Scale (HAM-D)40 score  19,
and absence of other comorbid psychiatric disorders
except generalized anxiety disorder (deﬁned by
SCID). Candidates were excluded if they intended to
attempt suicide in near future, had antisocial per-
sonality, had a Mini-Mental State Exam (MMSE)41
score  24 or dementia deﬁned by DSM-IV, could
not speak English, were receiving psychotherapy, or
planned to start a new antidepressant or change their
antidepressant’s dose.Interventions
Training and Fidelity. Twelve licensed clinical
social workers were trained by experts to provide
CM-PST and CM. Training consisted of a 2-day
workshop to review treatment manuals and to
engage in simulated case practice. Each therapist then
treated three practice cases. Their sessions were
audiotaped and reviewed by supervisors for certiﬁ-
cation. The training cases were not included in the
ﬁnal analyses. Therapists were monitored regularlyAm J Geriatr Psychiatry 23:12, December 2015for treatment ﬁdelity by independent raters using the
PST provider adherence checklist for the PST-CM
condition and the CM adherence checklist for the
CM condition. Clinicians were given corrective
feedback if any session fell below 4 (very good), and
any therapist who did not maintain an average
adherence score of 4 was excluded from the study
(N ¼ 2). Monthly supervision was provided for each
intervention, with Dr. Areán (UCSF) and Dr. Raue
(Cornell) providing CM-PST supervision and Ms.
Dwyer providing CM supervision. Therapists pro-
vided treatment in the participants’ homes.
Case Management. The CM intervention used for
this study is based on the clinical CM manual for
older adults with mental health problems developed
for the San Francisco County Department of Mental
Health, adapted for research (Appendix 1; available
online).32 CM begins with an assessment of partici-
pant’s social service needs and how well those needs
are being met using the CANE. Based on the
assessment, therapists develop a plan to link partic-
ipants to social and medical services. Therapists also
act as advocates for participants in situations where
participants cannot advocate effectively for them-
selves. To control for contact effects with CM-PST,
therapists met weekly with participants randomized
to CM for 12 weeks and were instructed not to
engage in any other interventions.
Case Management and Problem-Solving Therapy. CM-
PST is a combination of the CM intervention
described above and PST.27 In the ﬁrst session, ther-
apists conduct a needs assessment and educate par-
ticipants about problem-solving treatment. Therapists
then create a problem list and, with the help of par-
ticipants, divide problems into those that therapists
will solve through CM and those that participants can
solve using PST. In later sessions, therapists demon-
strate how PST works on speciﬁc problems and train
participants to use the PST approach for problems
they are able to solve. In follow-up sessions, thera-
pists check in on participant progress in solving their
own problems, help participants solve new problems,
and update participants about CM problems.Blinding
Research assistants were blind to treatment
assignment. Psychotherapy trials makes blinding
therapists to treatment conditions difﬁcult. However,1309
CM-PST vs. CM for Late-Life Disabilitytherapists were unaware of our hypotheses and had
separate meetings from the rest of the research team.
Assessment
Eligibility Assessment. Trained research assistants
administered the SCID-revised (SCID-R), HAM-D,
MMSE, CANE, and the multilevel assessment in-
strument. These data were then reviewed by two
clinician investigators to determine eligibility.
Primary Outcome. Disability, our primary
outcome, was determined using the total score on the
WHO Disability Assessment Scale II (WHODAS).42
We selected the WHODAS as the outcome measure
for disability because it treats all disorders at parity
when determining level of functioning and has been
validated in populations across the age span and
across cultures.30,43e50 The WHODAS is an
interviewer-administered instrument that combines
information from participant self-report and inter-
viewer observation to assess six functional domains:
understanding and communicating, getting around,
self-care, getting along with others, household and
work activities, and participation in society. The
WHODAS was administered at baseline and at 6, 9,
12, and 24 weeks. Participants were asked to report
on their function in these domains over the course of
3 weeks. This method of assessment is reliable and
has been used in depression studies.5,51
Other Assessments. We assessed the mediation
and/or prediction effects on disability, of severity of
depression (HAM-D), problem-solving skills, and self-
efﬁcacy. Problem-solving skills were measured with
the Brief COPE,52 which consists of active coping,
planning, positive reframing, denial, and behavioral
disengagement domains. Self-efﬁcacy was measured
using the General Perceived Self Efﬁcacy Scale
(GPSE), a measure of beliefs related to solving new
and complex tasks validated and normed in medical
and in older populations.53 The Brief COPE and the
GPSE were administered at baseline and at 12 weeks.
Power Analysis
We conducted power analysis to determine the
optimal sample size needed to detect a clinically
meaningful difference in disability between the two
interventions. Using an effect size of 0.35, a two-
tailed test with a ¼ 0.05, power ¼ 0.8, an intraclass
correlation coefﬁcient of 0.50, and six follow-up1310assessments, we determined that a total of 160 par-
ticipants (80 per condition) was adequate to test our
primary hypotheses. To determine our ability to
accurately test mediation effects, we also found that
80 participants per group would exceed 80% power
to detect a 5% change in R2 in the proposed
mediators.
Data Analysis
Using mixed-effects models for longitudinal data to
account for repeated measurements over time and
applying Kenward-Roger adjustments to the
denominator degrees of freedom to improve small
sampleperformance,we compared response proﬁles of
disability (baseline and 12 and 24 weeks) between the
two treatment conditions. We also examined whether
CMwasnoninferior toCM-PST in its effect ondisability
(WHODAS) from baseline to week 12, a common
process in clinical trials when intervention superiority
is not found.54e56 We used a noninferiority margin of
ﬁve-point change inWHODAS (measured on a scale of
0e100) based on Agency for Healthcare Research and
Quality recommendations for determining the mini-
mum important difference in clinical trials.57
All analyses were intention-to-treat. The mixed-
effects models included time effects, treatment
group, site, siteetreatment interaction, and time-
etreatment interaction. Three predictor analyses
were conducted using lagged values of the Brief
COPE, GPSE, and HAM-D scores over 12 weeks.
Moderation was assessed by checking the interaction
of baseline depression, MMSE, and unmet need with
treatment effects in the mixed-effects model
described above. Analyses were conducted using
SAS (version 9.1; SAS Institute, Cary, NC).RESULTS
Participant Flow and Sample Characteristics
An initial 271 participants were screened for eligi-
bility, 187 of whom met study criteria. Of these, 171
were consented and randomized: 87 participants
were randomized to CM and 84 to CM-PST. Of the
ﬁnal sample, 88% (N ¼ 150) completed the 12-week
assessment. There was no signiﬁcant difference in
drop-out between the two conditions (CM: 9;
CM-PST: 12). Most participants attended allAm J Geriatr Psychiatry 23:12, December 2015
Areán et al.treatment sessions, with 93% in CM and 91% in CM-
PST completing all sessions (Fig. 1).
The demographic characteristics of the sample
were published previously.35 Participants were on
average 74.9 years old (standard deviation [SD]: 9.3)
and had slightly above high school educations, with
an average of 13.2 years (SD: 2.9) of schooling. They
were moderately depressed (mean HAM-D score ¼
23) and had an average of 4.6 unmet social service
needs. Preliminary analyses found no signiﬁcant
differences between conditions or sites on age, edu-
cation, social service needs, or depression severity.
This was a moderately disabled population as
determined by baseline WHODAS scores (mean: 34;
SD: 7.4); scores of 25e49 correspond to moderate
disability.58 Although the sample all met criteria for
major depression, 26% received antidepressants atFIGURE 1. Flow of subjects into the treatment trial.
Am J Geriatr Psychiatry 23:12, December 2015therapeutic dosages and less than 21% were taking
benzodiazepines or sleep aides; no one was taking a
cognitive enhancer. There were no signiﬁcant differ-
ences in demographics, depression severity, or
disability between participants who had been on
antidepressants and those who had not.Outcomes
Changes in Disability. Analyses found a 3.8-point
improvement in disability for the whole sample
from baseline to week 12 (t ¼ 4.28, df ¼ 554,
p <0.0001). Change in disability occurred quickly,
with a 3.32-point improvement in disability by week
3 (t ¼ 4.26, df ¼ 601, p <0.0001). We found no
changes in disability scores between 12 and 24 weeks
(t ¼ 0.16, df ¼ 708, p ¼ 0.87) (Fig. 2).1311
CM-PST vs. CM for Late-Life DisabilityOutcomes between the two interventions were
similar over time. Participants in the CM condition
showed a smaller improvement in disability (a 2.6-
point change from baseline to week 12) than the
CM-PST group (a 3.8-change from baseline to week
12), but this was not a statistically signiﬁcant differ-
ence (estimated difference: 1.3; 95% conﬁdence
interval: 0.8 to 3.4; p ¼ 0.23, t ¼ 1.2, df ¼ 558).
Because the upper end of the conﬁdence interval was
3.4, we can assert that CM is noninferior to CM-PST
using the noninferiority margin of 5 (one-sided p ¼
0.0003, t ¼ 3.5, df ¼ 558).
Baseline Predictors of 12-week Outcome. Our original
intention for this study was to investigate potential
moderators of treatment response. However, because
we found no treatment differences, we investigated
pretreatment/baseline predictors of 12-week disability
for the whole sample. In particular, we were interested
in determining if number of unmet needs, severity of
depression, and cognitive function predicted out-
comes. We found that none of these baseline charac-
teristics was associated with treatment outcome.
People with large numbers of unmet needs did as well
as people with only a few unmet needs (F ¼ 1.70, df ¼
5, 545, p ¼ 0.38), and participants with more severe
depression at baseline improved as much as those
with moderate levels of depression (F ¼ 0.55, df ¼ 5,
570, p ¼ 0.70). Likewise, there was no effect of
cognitive function on 12-week disability (F ¼ 2.03,
df ¼ 5, 545, p ¼ 0.074).
Change-Related Predictors of 12-week Outcome. This
study was originally designed to test mediation ef-
fects of the difference in efﬁcacy of CM-PST versus
CM. However, mediation analysis would not be
meaningful because the efﬁcacy of CM was statisti-
cally indistinguishable from that of CM-PST. For thisFIGURE 2. WHODAS changes over time (adjusted means): CM
versus CM-PST.
1312reason, we examined whether change in variables
initially hypothesized as mediators predicted 12-week
disability scores in the entire sample. A mixed-effects
model demonstrated that change from baseline to 9
weeks in self-efﬁcacy (t ¼ 2.25, df ¼ 672, p <0.021),
problem solving (t ¼ 2.44, df ¼ 546, p ¼ 0.015), and
depression severity (t ¼ 2.50, df ¼ 672, p <0.025)
predicted the level of disability at 12 weeks.DISCUSSION
This study failed to demonstrate superiority of
CM-PST over CM in improving disability. Its most
important ﬁnding was that after 12 weeks of CM,
either alone or combined with PST, participants
experienced signiﬁcant improvements in function
and were able to maintain their improvement for an
additional 12 weeks after treatment ended. It is
important to highlight that the improvement in
disability in both treatments arms was both statisti-
cally and clinically signiﬁcant. Moreover, the beneﬁts
occurred rapidly, with marked improvement in
functioning seen as early as 3 weeks into treatment.
The absence of differences between interventions on
disability suggests that functional improvement was
largely driven by the CM intervention. Improvement
in depression, problem-solving skill development,
and increased self-efﬁcacy (i.e., the belief in one’s
ability to achieve personal goals) predicted changes in
disability over time across conditions. These ﬁndings
are consistent with studies in medically compromised
but nondepressed populations, where assistance with
negotiating complex healthcare systems and man-
aging chronic illnesses results in better well-being,
sense of self-efﬁcacy, and overall functioning.59e61
Although CM does not explicitly address psychopa-
thology, problem-solving, and self-efﬁcacy, it is likely
that when case managers address problems that feel
overwhelming to depressed, disabled, low-income
older adults, patients see that change is possible and
learn the process of solving these problems by
observing their case managers solve them.
This study’s ﬁndings should be viewed in the
context of its limitations. Participants in both condi-
tions received CM, and we did not include arms of
PST alone, unstructured CM, or usual care; the
study’s CM was structured and offered by trained
therapists whose quality of care was monitored.Am J Geriatr Psychiatry 23:12, December 2015
Areán et al.Therefore, it is unclear how the study’s structured
CM efﬁcacy compares with PST alone, unstructured
CM, usual care, or passage of time. However, all
participants had received unstructured CM by social
workers of the home-delivered services and had
failed to respond, as shoen by the presence of major
depression at study entry. Another limitation is the
absence of a performance measure of disability.
However, the WHODAS is based on both patient
self-report and rater observation and was developed
to capture the WHO concept of disability that en-
compasses physical and behavioral components.
We ﬁnd it encouraging that CM is noninferior to the
more complex CM-PST in reducing disability in
depressed, disabled, low-income older adults. Psy-
chotherapies are often too difﬁcult for frontline
workers to learn and sustain,62 and psychotherapies
are rarely usedwith ﬁdelity in social service settings.26
CM is an intervention that most social service workers
are trained to provide. Interventions and outcomes of
CMaremeasurable (e.g., linkage to services, improvedAm J Geriatr Psychiatry 23:12, December 2015functioning) and consistent with the Affordable Care
and the Mental Health Parity and Addiction Equity
Acts. Demonstrating that CMcan reduce disability in a
sick and often neglected older population provides a
reason for community-based social services to offer
training and supervision in structured CM so it can
reach the many impoverished, depressed, disabled
older adults in need of care.
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